These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 18790401

  • 21. Insulin-like growth factor 1, chromogranin A and prostate specific antigen serum levels in prostate cancer patients and controls.
    Marszalek M, Wachter J, Ponholzer A, Leitha T, Rauchenwald M, Madersbacher S.
    Eur Urol; 2005 Jul; 48(1):34-9. PubMed ID: 15967249
    [Abstract] [Full Text] [Related]

  • 22. Prevalence of prostate cancer at different levels of serum prostate-specific antigen (PSA) and different free: total PSA ratios in a consecutive series of men referred for prostate biopsies.
    Rydén L, Egevad L, Ekman P, Hellström M.
    Scand J Urol Nephrol; 2007 Jul; 41(4):302-7. PubMed ID: 17763221
    [Abstract] [Full Text] [Related]

  • 23. The role of a standardized 36 core template-assisted transperineal prostate biopsy technique in patients with previously negative transrectal ultrasonography-guided prostate biopsies.
    Pal RP, Elmussareh M, Chanawani M, Khan MA.
    BJU Int; 2012 Feb; 109(3):367-71. PubMed ID: 21883818
    [Abstract] [Full Text] [Related]

  • 24. The effect of percentage free prostate-specific antigen (PSA) level on the prostate cancer detection rate in a screening population with low PSA levels.
    Pelzer AE, Volgger H, Bektic J, Berger AP, Rehder P, Bartsch G, Horninger W.
    BJU Int; 2005 Nov; 96(7):995-8. PubMed ID: 16225515
    [Abstract] [Full Text] [Related]

  • 25. Cost-effectiveness of percent free PSA for prostate cancer detection in men with a total PSA of 4-10 ng/ml.
    Bermúdez-Tamayo C, Martín Martín JJ, González Mdel P, Pérez Romero C.
    Urol Int; 2007 Nov; 79(4):336-44. PubMed ID: 18025853
    [Abstract] [Full Text] [Related]

  • 26. Effects of systematic 12-core biopsy on the performance of percent free prostate specific antigen for prostate cancer detection.
    Canto EI, Singh H, Shariat SF, Kadmon D, Miles BJ, Wheeler TM, Slawin KM.
    J Urol; 2004 Sep; 172(3):900-4. PubMed ID: 15310993
    [Abstract] [Full Text] [Related]

  • 27. The value of a single biopsy with 12 transperineal cores for detecting prostate cancer in patients with elevated prostate specific antigen.
    Emiliozzi P, Longhi S, Scarpone P, Pansadoro A, DePaula F, Pansadoro V.
    J Urol; 2001 Sep; 166(3):845-50. PubMed ID: 11490231
    [Abstract] [Full Text] [Related]

  • 28. Individualized prostate biopsy strategy for Chinese patients with different prostate-specific antigen levels.
    Dai B, Ye DW, Kong YY, Shen YJ, Wang BH.
    Asian J Androl; 2008 Mar; 10(2):325-31. PubMed ID: 18097514
    [Abstract] [Full Text] [Related]

  • 29. Prebiopsy PSA velocity not reliable predictor of prostate cancer diagnosis, Gleason score, tumor location, or cancer volume after TTMB.
    Bittner N, Merrick GS, Andreini H, Taubenslag W, Allen ZA, Butler WM, Anderson RL, Adamovich E, Wallner KE.
    Urology; 2009 Jul; 74(1):171-6. PubMed ID: 19232691
    [Abstract] [Full Text] [Related]

  • 30. Prostate cancer risk with positive family history, normal prostate examination findings, and PSA less than 4.0 ng/mL.
    Canby-Hagino E, Hernandez J, Brand TC, Troyer DA, Higgins B, Ankerst DP, Thompson IM, Leach RJ, Parekh DJ.
    Urology; 2007 Oct; 70(4):748-52. PubMed ID: 17991549
    [Abstract] [Full Text] [Related]

  • 31. Increasing prostate biopsy cores based on volume vs the sextant biopsy: a prospective randomized controlled clinical study on cancer detection rates and morbidity.
    Mariappan P, Chong WL, Sundram M, Mohamed SR.
    BJU Int; 2004 Aug; 94(3):307-10. PubMed ID: 15291857
    [Abstract] [Full Text] [Related]

  • 32. Prostate cancer detection among men with prostate specific antigen levels of 2.5 to 4.0 ng/ml in a Japanese urological referral population.
    Kobayashi T, Mitsumori K, Kawahara T, Nishizawa K, Ogura K, Ide Y.
    J Urol; 2006 Apr; 175(4):1281-5. PubMed ID: 16515980
    [Abstract] [Full Text] [Related]

  • 33. Individualization of the biopsy protocol according to the prostate gland volume for prostate cancer detection.
    Eskicorapci SY, Guliyev F, Akdogan B, Dogan HS, Ergen A, Ozen H.
    J Urol; 2005 May; 173(5):1536-40. PubMed ID: 15821481
    [Abstract] [Full Text] [Related]

  • 34. [Cost analysis of ultrasound-guided transrectal needle biopsy in prostatic carcinoma].
    Bissoli E, Fandella A, La Torre E, Faggiano L, Anselmo G, Frasson F.
    Radiol Med; 1998 Apr; 95(4):353-6. PubMed ID: 9676215
    [Abstract] [Full Text] [Related]

  • 35. [Differentiation of prostate cancer from benign prostatic disease by total prostate specific antigen dynamic profiles after transrectal prostate biopsy].
    Shao Q, Song J, Zhou ZJ, Du LD.
    Zhonghua Nan Ke Xue; 2008 Jul; 14(7):597-601. PubMed ID: 18686378
    [Abstract] [Full Text] [Related]

  • 36. Improved prostate cancer detection with anterior apical prostate biopsies.
    Wright JL, Ellis WJ.
    Urol Oncol; 2006 Jul; 24(6):492-5. PubMed ID: 17138129
    [Abstract] [Full Text] [Related]

  • 37. Serum soluble Fas level for detection and staging of prostate cancer.
    Furuya Y, Fuse H, Masai M.
    Anticancer Res; 2001 Jul; 21(5):3595-8. PubMed ID: 11848529
    [Abstract] [Full Text] [Related]

  • 38. Evaluation of power Doppler ultrasonography for prostate biopsy in men with elevated serum prostate specific antigen levels.
    Ho CC, Khor TW, Singam P, Goh EH, Tan GH, Bahadzor B, Zulkifli MZ.
    Clin Ter; 2012 Jul; 163(3):211-4. PubMed ID: 22964693
    [Abstract] [Full Text] [Related]

  • 39. Detection rate of prostate cancer according to prostate-specific antigen and digital rectal examination in Korean men: a nationwide multicenter study.
    Seo HK, Chung MK, Ryu SB, Lee KH, Korean Urological Oncologic Society Prostate Cancer Study Group.
    Urology; 2007 Dec; 70(6):1109-12. PubMed ID: 18158028
    [Abstract] [Full Text] [Related]

  • 40. Impact of increased number of biopsies on the nature of prostate cancer identified.
    Meng MV, Elkin EP, DuChane J, Carroll PR.
    J Urol; 2006 Jul; 176(1):63-8; discussion 69. PubMed ID: 16753368
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.